Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-07-22, Stock:JNJ, The news for the past five days is as follows:
2020-07-15: NEWS1: Trading Johnson & Johnson Once It Reports Earnings.NEWS2: J&J's Tremfya Receives FDA Approval for Psoriatic Arthritis.NEWS3: Johnson & Johnson Is Poised (Again) for an Upside Breakout.NEWS4: Markets open higher on COVID-19 vaccine hopes.NEWS5: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS6: The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna, Novavax and Johnson & Johnson.NEWS7: The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent.
2020-07-16: NEWS1: Jim Cramer: An Analyst's Dream.NEWS2: Johnson & Johnson (JNJ) Q2 2020 Earnings Call Transcript.NEWS3: S&P 500 Falling: Airline Stocks, Cruise Stocks Crashing as 1.3 Million More File for Unemployment, Bank of America Prepares for Long Recession.NEWS4: Medical Bellwether J&J Slips Despite Handily Beating Quarterly Views.NEWS5: Stocks Finish Lower on Mixed Outlook for U.S. Recovery.NEWS6: Johnson & Johnson Dips on 2nd-Quarter Sales Decline.NEWS7: Here's Why AC Immune Jumped Higher Today.NEWS8: Johnson & Johnson's Revenue and Earnings Slipped in the Second Quarter.NEWS9: Dow Stumbles on Mixed Outlook for U.S. Recovery.NEWS10: Return On Capital Employed Overview: Johnson & Johnson.NEWS11: Covid Leaves Its Mark on Three Health Giants.NEWS12: Coronavirus update: Walmart, Target, CVS lead corporate push for face masks amid US case spike.NEWS13: Dow Jones Slumps as Johnson & Johnson Boosts Outlook, Apple and Cisco Stocks Head Lower.NEWS14: Johnson & Johnson's 2nd-Quarter Earnings and Revenue Beat Expectations.NEWS15: Johnson & Johnson CFO on Q2 earnings beat, unintended consequences of COVID-19.NEWS16: Stocks Fall, Tech Declines Pull Nasdaq Lower.NEWS17: Election 2020 isn’t among investors’ top concerns: Investopedia Anxiety Index.NEWS18: Johnson & Johnson Eyes Early Start to Phase III Vaccine Tests.NEWS19: P/E Ratio Insights for Johnson & Johnson.NEWS20: J&J (JNJ) Beats on Q2 Earnings & Sales, Ups 2020 Guidance.NEWS21: Johnson & Johnson Tops Q2 Earnings Forecast, Boosts 2020 Profit Outlook: Says Remains Committed to Coronavirus Vaccine Effort.NEWS22: Dow Falls as Global Recovery Picture Is Clouded.NEWS23: Bank of America profit slides in Q2 earnings; Johnson & Johnson earnings top expectations.NEWS24: These 10 Dividend Aristocrats Recently Raised Their Payouts.NEWS25: REFILE-J&J eyes September for late-stage study of potential COVID-19 vaccine.NEWS26: Johnson & Johnson Q2 Profit Plunges Over 35% as COVID-19 Hurts Sales; Analysts Still Optimistic.NEWS27: Johnson & Johnson (JNJ) Q2 Earnings and Revenues Beat Estimates.NEWS28: Dow Jones Futures: Who Will Lead Coronavirus Stock Market Rally? Netflix Earnings On Tap.NEWS29: Twitter Hack, Johnson & Johnson, American Airlines, Netflix - 5 Things You Must Know Thursday.NEWS30: Is ISRG Stock A Buy As The Robotic Surgery Giant Claws Back From A Low?.NEWS31: J&J to start Phase 1 trial for coronavirus vaccine candidate next week.NEWS32: Recap: Johnson & Johnson Q2 Earnings.NEWS33: Johnson & Johnson Earnings Top; Dow Jones Giant Raises Full-Year Guidance.NEWS34: Johnson & Johnson's stock inches up after profit and sales beat, raised outlook.NEWS35: J&J raises forecast after quarterly profit beats estimates.NEWS36: Johnson & Johnson profit tumbles 35% as COVID-19 slams medical device sales.
2020-07-17: NEWS1: Yacktman Fund Buys 2, Slims 4 Positions in 2nd Quarter.NEWS2: Why Moderna Stock Soared to a New All-Time High Today.NEWS3: Nasdaq Rises 29 as Intuitive Surgical Defies Robotic Surgery Competition; Moderna Jumps Again on Coronavirus Vaccine Prospects.NEWS4: Edited Transcript of JNJ earnings conference call or presentation 16-Jul-20 12:00pm GMT.NEWS5: Why Intuitive Surgical Stock Popped 8% on Friday.NEWS6: COVID-19 spike is 'abject failure' on the part of the federal govt. Doctor.NEWS7: Dow Jones Stocks Mixed As Biotechs Rise On Johnson & Johnson Vaccine News.NEWS8: Coronavirus cases surge to new records in U.S..NEWS9: J&J Sets in Motion Pharma Q2 Earnings: 3 Stocks to Buy.NEWS10: Johnson & Johnson Stock Is Too Cheap, Goldman Says.NEWS11: 3 Best Long-Term Stocks to Set and Forget.NEWS12: Dow Jones Today, Stocks Mixed As Netflix Disappoints, Biotechs Jump On J&J Vaccine News.NEWS13: Fauci urges U.S. to ‘regroup’ as COVID-19 cases surge.NEWS14: Stock Market Today With Jim Cramer: Johnson & Johnson Rises.NEWS15: Exclusive: EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines.NEWS16: Johnson & Johnson Says Late-Stage Coronavirus Vaccine Trials Moved Ahead To September.NEWS17: Manila May Return to Lockdown; Fauci Has Warning: Virus Update.
2020-07-20: NEWS1: Dividend Aristocrat Johnson & Johnson Declares Fresh Dividend; Yield Is 2.7%.NEWS2: Analyst: 'Vaccine disappointment,' coronavirus stimulus may let down investors, squash the rally.NEWS3: Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2020.NEWS4: Oxford vaccine shows good response in early human trials.NEWS5: How the Twitter Hack Could Have Been Worse.NEWS6: Benzinga's Top Upgrades, Downgrades For July 20, 2020.NEWS7: Abbott, J&J results buoyed by surprising June uptick in medical procedures even as coronavirus cases rise.NEWS8: Valneva eyes EU COVID-19 vaccine deal after agreeing to supply UK.
2020-07-21: NEWS1: Democratic lawmakers signal concern about coronavirus vaccine pricing, speed of development.NEWS2: Lawmaker Presses Drugmakers on Covid-19 Vaccine Pricing.NEWS3: House panel holds hearing with COVID-19 vaccine makers.NEWS4: Coronavirus update: US cases dip; vaccines take center stage in Congress as Trump re-starts briefings.NEWS5: Get Your Fixed-Income Fix in Dividend Stocks, Bernstein Analysts Say.NEWS6: Vaccine Makers Tell Congress They Are Hopeful, but Challenges Remain.NEWS7: Pharma giants to be pressed on 'vaccine effectiveness' in today's hearing: Healthcare Policy Analyst.NEWS8: Coronavirus vaccine developers vow diversity in clinical trials.NEWS9: 2 High-Yield Dividend Stocks I'd Buy Right Now.

Answer: Rise